A PILL TO FIGHT OBESITY IS ON THE VERGE OF APPROVAL

Summary from the TLDR newsletter

Eli Lilly has just released positive Phase III trial results for its experimental oral GLP-1 drug, orforglipron. People taking the drug experienced substantial improvements in weight loss and blood sugar control compared to those taking a placebo. It appeared to be as safe and tolerable as other existing GLP-1 drugs. The company now plans to apply for approval from the Food and Drug Administration, with a decision expected next year.